Barely Significant
← all excerpts

Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities.

Oncol Rep · 2025 · PMC11683451 · PMID 39704259

Europe PMCDOI
1
hedged sentence
0.0540
closest p · 1.1× alpha
0.0540
boldest claim

The sentences

did not reach statistical significanceP=0.054so close (0.05 < p ≤ 0.1)
Of the 474 patients treated with EGFR inhibitors, patients with heart disease had a higher rate of cardiotoxicities (3.4%) than those with other comorbidities (0.6%), although the differences did not reach statistical significance (P=0.054).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.